[go: up one dir, main page]

GB0802754D0 - Antisense RNA targetting CXCR4 - Google Patents

Antisense RNA targetting CXCR4

Info

Publication number
GB0802754D0
GB0802754D0 GBGB0802754.2A GB0802754A GB0802754D0 GB 0802754 D0 GB0802754 D0 GB 0802754D0 GB 0802754 A GB0802754 A GB 0802754A GB 0802754 D0 GB0802754 D0 GB 0802754D0
Authority
GB
United Kingdom
Prior art keywords
targetting
cxcr4
antisense rna
antisense
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0802754.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST SUPERIORE DI SANITO
Original Assignee
INST SUPERIORE DI SANITO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST SUPERIORE DI SANITO filed Critical INST SUPERIORE DI SANITO
Priority to GBGB0802754.2A priority Critical patent/GB0802754D0/en
Publication of GB0802754D0 publication Critical patent/GB0802754D0/en
Priority to PCT/EP2009/001300 priority patent/WO2009100955A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C12N2310/141—MicroRNAs, miRNAs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0802754.2A 2008-02-14 2008-02-14 Antisense RNA targetting CXCR4 Ceased GB0802754D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0802754.2A GB0802754D0 (en) 2008-02-14 2008-02-14 Antisense RNA targetting CXCR4
PCT/EP2009/001300 WO2009100955A1 (en) 2008-02-14 2009-02-16 Antisense rna targeting cxcr4

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0802754.2A GB0802754D0 (en) 2008-02-14 2008-02-14 Antisense RNA targetting CXCR4

Publications (1)

Publication Number Publication Date
GB0802754D0 true GB0802754D0 (en) 2008-03-26

Family

ID=39271725

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0802754.2A Ceased GB0802754D0 (en) 2008-02-14 2008-02-14 Antisense RNA targetting CXCR4

Country Status (2)

Country Link
GB (1) GB0802754D0 (en)
WO (1) WO2009100955A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9696312B2 (en) 2011-09-02 2017-07-04 The Trustees Of Columbia University In The City Of New York Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand
WO2013036282A2 (en) * 2011-09-07 2013-03-14 The Trustees Of Columbia University In The City Of New York Downregulation of inflammatory micrornas by ilt3
AU2012308092A1 (en) * 2011-09-13 2014-04-17 Commonwealth Scientific And Industrial Research Organisation Detection of viral infection
WO2016179417A2 (en) * 2015-05-06 2016-11-10 The University Of Utah Research Foundation Exosome delivery of micrornas
US11980663B2 (en) * 2015-07-08 2024-05-14 American Gene Technologies International Inc. HIV pre-immunization and immunotherapy
WO2017015227A1 (en) 2015-07-17 2017-01-26 The Trustees Of Columbia University In The City Of New York Methods of treating cd166-expressing cancer
JP7153332B2 (en) 2016-02-08 2022-10-14 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド HIV vaccination and immunotherapy
AU2017292582C1 (en) 2016-07-08 2021-11-11 American Gene Technologies International Inc. HIV pre-immunization and immunotherapy
US12031149B2 (en) * 2019-03-27 2024-07-09 Emendobio Inc. Compositions and methods for promoting gene editing of CXCR4 gene
CN110917359A (en) * 2019-11-21 2020-03-27 武汉理工大学 Preparation of PEG-P(Asp-AP)-ANTAGOMIR-RNA Microspheres by Ionic Bond Self-assembly

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2323525C (en) * 1998-03-30 2011-03-01 Gerald P. Murphy Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
AU1408300A (en) * 1998-11-24 2000-06-13 Hisamitsu Pharmaceutical Co. Inc. Hiv infection inhibitors
CA3024953A1 (en) * 2006-04-03 2007-10-11 Roche Innovation Center Copenhagen A/S Pharmaceutical composition comprising anti-mirna antisense oligonucleotides

Also Published As

Publication number Publication date
WO2009100955A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
GB0802754D0 (en) Antisense RNA targetting CXCR4
EP2069496A4 (en) Improved selex and photoselex
ZA201202608B (en) Hbv antisense inhibitors
PL2837383T3 (en) Immunity-inducing agent
IL215682A0 (en) Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease
IL201183A0 (en) Administering antisense oligonucleotides complementary to human apolipoprotein b
EP2331154A4 (en) Nanoparticle-stem cell conjugates for post-infarction treatment
EP2255730A4 (en) Ultrasonograph
IL209697A0 (en) Dermal delivery
EP2501369A4 (en) Drug-loaded fibers
EP2410859A4 (en) Transdermal delivery
GB0918579D0 (en) Gadd45beta targeting agents
ZA201100093B (en) Novel genes involved in biosynthesis
GB0816778D0 (en) Gene silencing
IL217766A (en) Flavour active composition
IL217428A0 (en) Sparc antisense compositions and uses thereof
ZA201203851B (en) Activity generating delivery molecules
GB0803054D0 (en) Medicament
EP2300019A4 (en) Antisense formulation
IL207290A0 (en) CATIONIC siRNAs, SYNTHESIS AND USE FOR INTERFERING RNA
EP2322608A4 (en) Transfection agent
EP2343964A4 (en) Transdermal delivery
EP2086591A4 (en) Efficient nuclear delivery of antisense oligonucleotides
GB0917792D0 (en) Delivery agent
GB0903562D0 (en) RNA molecules

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)